Literature DB >> 17634918

Nice insulins, pity about the evidence.

F Holleman1, E A M Gale2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17634918     DOI： 10.1007/s00125-007-0763-4

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  26 in total

Review 1.  Lessons from the glitazones: a story of drug development.

Authors:  E A Gale
Journal:  Lancet       Date:  2001-06-09       Impact factor: 79.321

2.  An observational study found that authors of randomized controlled trials frequently use concealment of randomization and blinding, despite the failure to report these methods.

Authors:  P J Devereaux; Peter T-L Choi; Samer El-Dika; Mohit Bhandari; Victor M Montori; Holger J Schünemann; Amit X Garg; Jason W Busse; Diane Heels-Ansdell; William A Ghali; Braden J Manns; Gordon H Guyatt
Journal:  J Clin Epidemiol       Date:  2004-12       Impact factor: 6.437

3.  The market in diabetes.

Authors:  Alexandra Hauber; Edwin A M Gale
Journal:  Diabetologia       Date:  2006-02       Impact factor: 10.122

4.  Recrystallized insulin for diabetic patients with insulin allergy.

Authors:  J E JORPES
Journal:  Arch Intern Med (Chic)       Date:  1949-04

5.  Systematic evaluation of the quality of randomized controlled trials in diabetes.

Authors:  Victor M Montori; Yaqian Grace Wang; Pablo Alonso-Coello; Sumit Bhagra
Journal:  Diabetes Care       Date:  2006-08       Impact factor: 19.112

6.  Initiating insulin therapy in type 2 Diabetes: a comparison of biphasic and basal insulin analogs.

Authors:  Philip Raskin; Elsie Allen; Priscilla Hollander; Andrew Lewin; Robert A Gabbay; Peter Hu; Bruce Bode; Alan Garber
Journal:  Diabetes Care       Date:  2005-02       Impact factor: 19.112

7.  Double-blind crossover comparison of human and porcine insulins in patients reporting lack of hypoglycaemia awareness.

Authors:  S Colagiuri; J J Miller; P Petocz
Journal:  Lancet       Date:  1992-06-13       Impact factor: 79.321

8.  The mechanism of protraction of insulin detemir, a long-acting, acylated analog of human insulin.

Authors:  Svend Havelund; Anne Plum; Ulla Ribel; Ib Jonassen; Aage Vølund; Jan Markussen; Peter Kurtzhals
Journal:  Pharm Res       Date:  2004-08       Impact factor: 4.200

Review 9.  Biosynthetic human proinsulin. Review of chemistry, in vitro and in vivo receptor binding, animal and human pharmacology studies, and clinical trial experience.

Authors:  J A Galloway; S A Hooper; C T Spradlin; D C Howey; B H Frank; R R Bowsher; J H Anderson
Journal:  Diabetes Care       Date:  1992-05       Impact factor: 19.112

10.  Interval between insulin injection and eating in relation to blood glucose control in adult diabetics.

Authors:  M E Lean; L L Ng; B R Tennison
Journal:  Br Med J (Clin Res Ed)       Date:  1985-01-12
View more
  17 in total

1.  Omitting breakfast and lunch after injection of different long-acting insulin preparations at bedtime: a prospective study in patients with type 2 diabetes.

Authors:  P Wiesli; P Krayenbühl; H Uthoff; B Seifert; C Schmid
Journal:  Diabetologia       Date:  2009-06-30       Impact factor: 10.122

Review 2.  Using insulin in type 2 diabetes: in need of a renaissance?

Authors:  David Kerr; Tolulope Olateju
Journal:  J Diabetes Sci Technol       Date:  2011-07-01

3.  Does diabetes therapy influence the risk of cancer?

Authors:  U Smith; E A M Gale
Journal:  Diabetologia       Date:  2009-09       Impact factor: 10.122

Review 4.  Evidence-informed clinical practice recommendations for treatment of type 1 diabetes complicated by problematic hypoglycemia.

Authors:  Pratik Choudhary; Michael R Rickels; Peter A Senior; Marie-Christine Vantyghem; Paola Maffi; Thomas W Kay; Bart Keymeulen; Nobuya Inagaki; Frantisek Saudek; Roger Lehmann; Bernhard J Hering
Journal:  Diabetes Care       Date:  2015-06       Impact factor: 19.112

5.  The insulin dilemma in resource-limited countries. A way forward?

Authors:  G V Gill; J S Yudkin; H Keen; D Beran
Journal:  Diabetologia       Date:  2010-09-12       Impact factor: 10.122

6.  The interpretation of glucose clamp studies of long-acting insulin analogues: from physiology to marketing and back.

Authors:  S G H A Swinnen; F Holleman; J H DeVries
Journal:  Diabetologia       Date:  2008-08-01       Impact factor: 10.122

Review 7.  Short-acting insulin analogues versus regular human insulin for adults with type 1 diabetes mellitus.

Authors:  Birgit Fullerton; Andrea Siebenhofer; Klaus Jeitler; Karl Horvath; Thomas Semlitsch; Andrea Berghold; Johannes Plank; Thomas R Pieber; Ferdinand M Gerlach
Journal:  Cochrane Database Syst Rev       Date:  2016-06-30

8.  Establishing glycaemic control with continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes: experience of the PedPump Study in 17 countries.

Authors:  T Danne; T Battelino; P Jarosz-Chobot; O Kordonouri; E Pánkowska; J Ludvigsson; E Schober; E Kaprio; T Saukkonen; M Nicolino; N Tubiana-Rufi; C Klinkert; H Haberland; A Vazeou; L Madacsy; D Zangen; V Cherubini; I Rabbone; S Toni; C de Beaufort; W Bakker-van Waarde; N van den Berg; I Volkov; R Barrio; R Hanas; U Zumsteg; B Kuhlmann; C Aebi; U Schumacher; S Gschwend; P Hindmarsh; M Torres; N Shehadeh; M Phillip
Journal:  Diabetologia       Date:  2008-07-01       Impact factor: 10.122

Review 9.  Circadian clocks and insulin resistance.

Authors:  Dirk Jan Stenvers; Frank A J L Scheer; Patrick Schrauwen; Susanne E la Fleur; Andries Kalsbeek
Journal:  Nat Rev Endocrinol       Date:  2019-02       Impact factor: 43.330

Review 10.  Insulin therapy for type 2 diabetes.

Authors:  Sanne G Swinnen; Joost B Hoekstra; J Hans DeVries
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.